Stoke Therapeutics, Inc.
Status: Publicly traded
Direct answer
Stoke Therapeutics, Inc. is publicly traded on NASDAQ under the ticker STOK.
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States. The company employs its exclusive Targeted Augmentation of Nuclear Gene Output (TANGO) platform to engineer ASOs that precisely enhance...
Can you invest in Stoke Therapeutics, Inc.?
Yes. Stoke Therapeutics, Inc. trades publicly on NASDAQ as STOK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Stoke Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.